Publications by authors named "Concepcion Nicolas"

Claim this Profile
T
Tafasitamab plus lenalidomide as salvage therapy in diffuse large B-cell lymphoma: real-world experience from GELTAMO.
Antonio Gutierrez, Izaskun Zeberio, Francisco Javier Peñalver, Pilar Martinez-Barranco, Sandra Perez, Concepcion Nicolas

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic subtyping by Whole Exome Sequencing across Diffuse Large B Cell Lymphoma and Plasmablastic Lymphoma.
Aitana Avendaño Pomares, Laura Rodríguez Merino, Sonia González, Jordi Morata, Raúl Tonda

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Septic Arthritis, a Clinic Challenge.
Carlos Suárez-Cuervo, Concepción Nicolás, Jonathan Fernández-Suárez, Ana Morilla, Javier Fernández

Diagnostics (Basel)· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.
Koichi Oshima, Junfei Zhao, Pablo Pérez-Durán, Jessie A Brown, Juan Angel Patiño-Galindo, Concepcion Nicolas

Nat Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Value of Adding Surveillance Cultures to Fluoroquinolone Prophylaxis in the Management of Multiresistant Gram Negative Bacterial Infections in Acute Myeloid Leukemia.
Christelle Castañón, Ahinoa Fernández Moreno, Ana María Fernández Verdugo, Javier Fernández, Carmen Martínez Ortega

J Clin Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study.
Jimena Cannata-Ortiz, Concepción Nicolás, Ana García-Noblejas, María José Requena, Javier López-Jiménez

Br J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Antonio Salar, Eva Domingo-Domenech, Carlos Panizo, Concepción Nicolás, Joan Bargay

Blood· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.
Koichi Oshima, Hossein Khiabanian, Ana C da Silva-Almeida, Gannie Tzoneva, Francesco Abate, Concepción Nicolas

Proc Natl Acad Sci U S A· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial.
Antonio Salar, Eva Domingo-Domenech, Carlos Panizo, Concepción Nicolás, Joan Bargay

Lancet Haematol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.
Sandra Quijano, Antonio López, Juan Manuel Sancho, Carlos Panizo, Guillermo Debén

J Clin Oncol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
Juan-Manuel Sancho, Mireia Morgades, Reyes Arranz, Pascual Fernández-Abellán, Guillermo Deben

Med Clin (Barc)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain.
Juan-Manuel Sancho, Mireia Morgades, Natalia Alonso, Guillermo Deben, Alberto Fernández de Sevilla

Med Clin (Barc)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.
Abel Sánchez-Aguilera, Carlos Montalbán, Paloma de la Cueva, Lydia Sánchez-Verde, Manuel M Morente

Blood· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High molecular response rate and clinical correlation in patients with follicular lymphoma treated with cyclophosphamide-vincristine-prednisone plus interferon alpha 2b.
Elena Fernández-Ruiz, María Cabrerizo, Mara Ortega, Carlos Blas, Pilar Llamas

Clin Cancer Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis